These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28124536)

  • 1. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
    Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
    Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome.
    Downey A; Hennessy DB; Curry D; Cartwright C; Downey P; Pahuja A
    Ulster Med J; 2015 Oct; 84(3):161-3. PubMed ID: 26668417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS).
    Moss NP; Chill HH; Sand PK; Chang C; Goldberg RP; Gafni-Kane A
    Neurourol Urodyn; 2023 Mar; 42(3):615-622. PubMed ID: 36747494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: a prospective, randomized, comparative study.
    Gallego-Vilar D; García-Fadrique G; Povo-Martin I; Salvador-Marin M; Gallego-Gomez J
    Urol Int; 2013; 90(4):411-6. PubMed ID: 23485788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
    Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
    BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.
    Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E
    Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical treatments for painful bladder syndrome/ interstitial cystitis.
    Dawson TE; Jamison J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006113. PubMed ID: 17943887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis.
    Stav K; Beberashvili I; Lindner A; Leibovici D
    Urology; 2012 Jul; 80(1):61-5. PubMed ID: 22748865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome.
    Nickel JC; Egerdie RB; Steinhoff G; Palmer B; Hanno P
    Urology; 2010 Oct; 76(4):804-9. PubMed ID: 20494413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.
    Cervigni M; Natale F; Nasta L; Padoa A; Voi RL; Porru D
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):943-7. PubMed ID: 18338095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
    Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
    Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which bladder instillations are more effective? DMSO vs. bupivacaine/heparin/triamcinolone: a retrospective study.
    Iyer S; Lotsof E; Zhou Y; Tran A; Botros C; Sand P; Goldberg R; Tomezsko J; Gafni-Kane A; Botros S
    Int Urogynecol J; 2017 Sep; 28(9):1335-1340. PubMed ID: 28150028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questionnaire-guided evaluation of the effectiveness of long-term intravesical 0.2% chondroitin sulfate therapy in interstitial cystitis.
    Kocatürk H; Atasoy N; Bedir F; Altay MS; Demirdöğen ŞO; Koç E; Yilmaz S
    Int Urogynecol J; 2021 May; 32(5):1293-1298. PubMed ID: 32047969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.